Estados financieros detallados de ADMA Biologics, Inc. (ADMA): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
ADMA Biologics, Inc. registró ingresos de $510.2M en el último ejercicio fiscal, con un CAGR de 5 años del 64.6%.
Márgenes de los últimos 12 meses: margen bruto 64.7%, margen operativo 42.3%, margen neto 33.0%.
Al precio actual de $8.90, ADMA cotiza a un P/E de 12.55 y un ROE del 30.78%. La capitalización bursátil es de $2.1B.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $10.7M | $22.8M | $17.0M | $29.3M | $42.2M | $80.9M | $154.1M | $258.2M | $426.5M | $510.2M |
| Coste de Ventas | $6.4M | $29.2M | $42.2M | $39.5M | $61.3M | $79.8M | $118.8M | $169.3M | $206.9M | $217.4M |
| Beneficio Bruto | $4.3M | -$6.4M | -$25.2M | -$10.2M | -$19.1M | $1.2M | $35.3M | $88.9M | $219.6M | $292.8M |
| I+D | $7.7M | $6.2M | $3.9M | $2.3M | $5.9M | $3.6M | $3.6M | $3.3M | $1.8M | $4.8M |
| Generales y Administrativos | $8.5M | $18.1M | $22.5M | $25.9M | $35.1M | $42.9M | $52.5M | $59.0M | $74.1M | $91.6M |
| Gastos Operativos | $21.6M | $32.1M | $35.1M | $31.3M | $45.8M | $59.5M | $74.6M | $67.3M | $80.6M | $101.3M |
| Beneficio Operativo | -$17.3M | -$39.3M | -$60.3M | -$41.4M | -$64.9M | -$58.4M | -$39.4M | $21.6M | $139.0M | $191.4M |
| EBITDA | -$16.8M | -$39.3M | -$56.8M | -$36.0M | -$59.8M | -$53.1M | -$39.5M | $5.1M | $147.7M | $197.9M |
| Gastos por Intereses | $2.2M | $3.3M | $5.5M | $9.0M | $12.0M | $13.1M | $19.3M | $25.0M | $13.9M | $7.1M |
| Beneficio Antes de Impuestos | -$19.5M | -$43.8M | -$65.7M | -$48.3M | -$75.7M | -$71.6M | -$65.9M | -$28.2M | $125.7M | $182.7M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$72.0M | $35.7M |
| Beneficio Neto | -$19.5M | -$43.8M | -$65.7M | -$48.3M | -$75.7M | -$71.6M | -$65.9M | -$28.2M | $197.7M | $146.9M |
| BPA | $-1.61 | $-1.91 | $-1.45 | $-1.05 | $-1.02 | $-0.61 | $-0.43 | $-0.13 | $0.85 | $0.62 |
| BPA Diluido | $-1.61 | $-1.91 | $-1.45 | $-1.05 | $-1.02 | $-0.61 | $-0.43 | $-0.13 | $0.81 | $0.60 |
| Acciones en Circulación (Diluidas) | $12.2M | $22.9M | $45.2M | $54.3M | $86.1M | $139.6M | $197.9M | $224.0M | $243.3M | $244.9M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $9.9M | $43.1M | $22.8M | $26.8M | $55.9M | $51.1M | $86.5M | $51.4M | $103.1M | $87.6M |
| Inversiones a Corto | $5.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $1.0M | $3.9M | $1.4M | $3.5M | $13.2M | $28.6M | $15.5M | $27.4M | $50.0M | $158.4M |
| Inventario | $5.0M | $12.6M | $18.6M | $53.1M | $81.5M | $124.7M | $163.3M | $172.9M | $170.2M | $206.5M |
| Activos Corrientes | $21.7M | $63.2M | $44.5M | $85.8M | $153.7M | $208.7M | $270.4M | $257.0M | $331.4M | $466.5M |
| Inmovilizado Material | $2.0M | $30.5M | $30.1M | $33.0M | $45.9M | $58.2M | $68.7M | $63.5M | $63.3M | $71.7M |
| Fondo de Comercio | 0 | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M |
| Activos Intangibles | 0 | $4.8M | $4.0M | $3.2M | $2.4M | $1.7M | $1.0M | $499000 | $460000 | $632000 |
| Activos Totales | $23.7M | $108.0M | $88.9M | $127.1M | $207.7M | $276.3M | $348.5M | $329.2M | $488.7M | $624.2M |
| Cuentas por Pagar | $2.6M | $5.9M | $5.9M | $9.2M | $11.1M | $12.4M | $13.2M | $15.7M | $20.2M | $22.5M |
| Deuda a Corto | $6.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $2.8M |
| Pasivos Corrientes | $11.2M | $9.4M | $9.6M | $14.0M | $19.9M | $30.4M | $39.3M | $49.8M | $55.5M | $69.5M |
| Deuda a Largo | $14.1M | $43.0M | $44.1M | $83.2M | $93.0M | $94.9M | $142.8M | $130.6M | $72.3M | $69.3M |
| Pasivos Totales | $28.1M | $67.7M | $69.1M | $100.9M | $119.4M | $135.1M | $196.5M | $194.0M | $139.7M | $146.9M |
| Reservas | -$106.9M | -$150.7M | -$216.4M | -$264.7M | -$340.5M | -$412.1M | -$478.0M | -$506.3M | -$308.6M | -$161.7M |
| Patrimonio Neto | -$4.5M | $40.3M | $19.8M | $26.2M | $88.2M | $141.2M | $152.0M | $135.2M | $349.0M | $477.3M |
| Deuda Total | $20.3M | $43.0M | $44.2M | $84.7M | $97.7M | $102.9M | $154.4M | $141.4M | $82.1M | $79.9M |
| Deuda Neta | $5.0M | -$136720 | $21.5M | $58.0M | $41.7M | $51.8M | $67.9M | $90.1M | -$21.0M | -$7.7M |
| Capital Circulante | $10.4M | $53.7M | $34.9M | $71.8M | $133.8M | $178.4M | $231.1M | $207.2M | $275.9M | $397.0M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$19.5M | -$43.8M | -$65.7M | -$48.3M | -$75.7M | -$71.6M | -$65.9M | -$28.2M | $197.7M | $146.9M |
| Amortizaciones | $469576 | $2.7M | $3.4M | $3.3M | $3.9M | $5.5M | $7.1M | $8.3M | $8.0M | $8.1M |
| Compensación en Acciones | $1.3M | $1.6M | 0 | $2.7M | $2.9M | $3.5M | $5.2M | $6.2M | $13.6M | $20.0M |
| Cambio en Capital Circulante | -$1.0M | -$282242 | -$3.7M | -$33.5M | -$33.8M | -$51.7M | -$18.3M | -$10.1M | -$18.5M | -$139.6M |
| Flujo de Caja Operativo | -$18.3M | -$37.3M | -$62.7M | -$76.2M | -$102.0M | -$112.4M | -$59.5M | $8.8M | $118.7M | $50.4M |
| Inversiones (CapEx) | -$73410 | -$2.7M | -$2.1M | -$3.8M | -$12.7M | -$13.5M | -$13.9M | -$5.0M | -$8.6M | -$22.6M |
| Adquisiciones | 0 | $12.5M | 0 | 0 | $2000 | 0 | 0 | 0 | 0 | $1.0M |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$1.4M | 0 | -$31.9M |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$18.3M | -$39.9M | -$64.8M | -$80.0M | -$114.7M | -$125.9M | -$73.4M | $3.8M | $110.1M | $27.8M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +113.5% | -25.4% | +72.8% | +43.9% | +91.7% | +90.4% | +67.6% | +65.2% | +19.6% | |
| Crecimiento Beneficio Neto (anual) | -124.2% | -50.2% | +26.6% | -56.9% | +5.4% | +8.0% | +57.2% | +800.0% | -25.7% | |
| Crecimiento BPA (anual) | -18.6% | +24.1% | +27.6% | +2.9% | +40.2% | +29.5% | +69.8% | +753.8% | -27.1% | |
| Cambio en Acciones (anual) | +88.4% | +97.4% | +20.3% | +58.5% | +62.0% | +41.8% | +13.2% | +8.6% | +0.6% | |
| Crecimiento FCF (anual) | -117.8% | -62.1% | -23.5% | -43.4% | -9.7% | +41.7% | +105.2% | +2782.9% | -74.7% | |
| Margen Bruto | 40.3% | -28.1% | -148.4% | -34.6% | -45.2% | 1.4% | 22.9% | 34.4% | 51.5% | 57.4% |
| Margen Operativo | -162.6% | -172.7% | -354.9% | -141.1% | -153.8% | -72.1% | -25.5% | 8.4% | 32.6% | 37.5% |
| Margen EBITDA | -157.6% | -172.7% | -334.3% | -122.8% | -141.7% | -65.6% | -25.6% | 2.0% | 34.6% | 38.8% |
| Margen Neto | -183.1% | -192.3% | -387.1% | -164.5% | -179.4% | -88.5% | -42.8% | -10.9% | 46.4% | 28.8% |
| Margen FCF | -172.1% | -175.5% | -381.4% | -272.6% | -271.7% | -155.5% | -47.7% | 1.5% | 25.8% | 5.5% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -57.2% | 19.6% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-1.51 | $-1.74 | $-1.43 | $-1.47 | $-1.33 | $-0.90 | $-0.37 | $0.02 | $0.45 | $0.11 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $12.2M | $22.9M | $45.2M | $54.3M | $86.1M | $139.6M | $197.9M | $224.0M | $233.1M | $238.3M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 30.78% |
| Rentabilidad sobre capital invertido | 27.57% |
| Rentabilidad sobre activos | 23.54% |
| Margen bruto | 64.71% |
| Margen operativo | 42.26% |
| Margen neto | 32.98% |
Salud financiera
| Deuda / Patrimonio | 0.50 |
| Ratio corriente | 6.97 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 19.98 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -3.18 | -1.68 | -1.65 | -3.81 | -1.91 | -2.31 | -9.02 | -34.77 | 20.18 | 29.42 |
| P/VC | -13.96 | 1.82 | 5.46 | 8.30 | 1.90 | 1.39 | 5.05 | 7.49 | 11.45 | 9.11 |
| P/V | 5.84 | 3.23 | 6.36 | 7.41 | 3.98 | 2.43 | 4.98 | 3.92 | 9.37 | 8.52 |
| Margen Bruto | 40.3% | -28.1% | -148.4% | -34.6% | -45.2% | 1.4% | 22.9% | 34.4% | 51.5% | 57.4% |
| Margen Operativo | -162.6% | -172.7% | -354.9% | -141.1% | -153.8% | -72.1% | -25.5% | 8.4% | 32.6% | 37.5% |
| Margen Neto | -183.1% | -192.3% | -387.1% | -164.5% | -179.4% | -88.5% | -42.8% | -10.9% | 46.4% | 28.8% |
Empresas relacionadas: ACAD · BLTE · CRNX · DYN · LGND · MIRM · PRAX
Explorar sector: Healthcare · Biotechnology
Más secciones de ADMA: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones